Skip to main content
Top
Published in: International Journal of Legal Medicine 3/2019

01-05-2019 | Original Article

Post-mortem in situ stability of serum markers of cerebral damage and acute phase response

Authors: Benjamin Ondruschka, Lina Woydt, Michael Bernhard, Heike Franke, Holger Kirsten, Sabine Löffler, Dirk Pohlers, Niels Hammer, Jan Dreßler

Published in: International Journal of Legal Medicine | Issue 3/2019

Login to get access

Abstract

The aim of the given study was to test the in situ stability of biochemical markers of cerebral damage and acute phase response in the early post-mortem interval to assess their usability for forensic pathology. A monocentric, prospective study investigated post-mortem femoral venous blood samples at four time points obtained within 48 h post-mortem starting at the death of 20 deceased, using commercial immunoassays for the ten parameters: S100 calcium-binding protein B (S100B), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), interleukin-6 (IL-6), C-reactive protein (CRP), procalcitonin (PCT), ferritin, soluble tumor necrosis factor receptor type 1 (sTNFR1), and lactate dehydrogenase (LDH). Significant changes in serum levels were observed only later than 2 h after death for all markers. Inter-laboratory comparability was high, and intra-assay precision was sufficient for most markers. Most of the biomarker levels depended on the severity of hemolysis and lipemia but were robust against freeze-thaw cycles. Serum levels increased with longer post-mortem intervals for S100B, NSE, ferritin, sTNFR1, and LDH (for all p < 0.001) but decreased over this period for CRP (p = 0.089) and PCT (p < 0.001). Largely unchanged median values were found for GFAP (p = 0.139), BDNF (p = 0.106), and IL-6 (p = 0.094). Serum levels of CRP (p = 0.059) and LDH (p = 0.109) did not differ significantly between the final ante-mortem (resuscitation) and the first post-mortem sample (moment of death). Collecting the post-mortem blood sample as soon as possible will reduce the influence of post-mortem blood changes. Serum GFAP for detection of cerebral damage as well as serum IL-6 and CRP as proof of acute phase response seemed to be preferable due to their in situ stability in the first 2 days after death.
Literature
1.
go back to reference Coe J (1993) Post-mortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14:91–111PubMed Coe J (1993) Post-mortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14:91–111PubMed
2.
go back to reference Palmiere C, Mangin P (2012a) Post-mortem chemistry update part I. Int J Legal Med 126:187–198PubMed Palmiere C, Mangin P (2012a) Post-mortem chemistry update part I. Int J Legal Med 126:187–198PubMed
3.
go back to reference Palmiere C, Mangin P (2012b) Post-mortem chemistry update part II. Int J Legal Med 126:199–215PubMed Palmiere C, Mangin P (2012b) Post-mortem chemistry update part II. Int J Legal Med 126:199–215PubMed
4.
go back to reference Maeda H, Zhu BL, Ishikawa T, Quan L, Michiue T (2009) Significance of post-mortem biochemistry in determining the cause of death. Legal Med 11:46–49 Maeda H, Zhu BL, Ishikawa T, Quan L, Michiue T (2009) Significance of post-mortem biochemistry in determining the cause of death. Legal Med 11:46–49
5.
go back to reference Luna A (2009) Is post-mortem biochemistry really useful? Why is it not widely used in forensic pathology? Legal Med 11:27–30 Luna A (2009) Is post-mortem biochemistry really useful? Why is it not widely used in forensic pathology? Legal Med 11:27–30
6.
go back to reference Ondruschka B, Schuch S, Pohlers D, Franke H, Dreßler J (2018) Acute phase response after fatal traumatic brain injury. Int J Legal Med 132:531–539.PubMed Ondruschka B, Schuch S, Pohlers D, Franke H, Dreßler J (2018) Acute phase response after fatal traumatic brain injury. Int J Legal Med 132:531–539.PubMed
7.
go back to reference Ondruschka B, Sieber M, Kirsten H; Franke H, Dreßler J (2018) Measurement of cerebral biomarkers proving traumatic brain injuries in post-mortem body fluids. J Neurotrauma 35:2044–2055.PubMed Ondruschka B, Sieber M, Kirsten H; Franke H, Dreßler J (2018) Measurement of cerebral biomarkers proving traumatic brain injuries in post-mortem body fluids. J Neurotrauma 35:2044–2055.PubMed
8.
go back to reference Sieber M, Dreßler J, Franke, Pohlers D, Ondruschka B (2018) Post-mortem biochemistry of NSE and S100B. A supplemental tool for detecting a lethal traumatic brain injury? J Forensic Legal Med 55:65–73. Sieber M, Dreßler J, Franke, Pohlers D, Ondruschka B (2018) Post-mortem biochemistry of NSE and S100B. A supplemental tool for detecting a lethal traumatic brain injury? J Forensic Legal Med 55:65–73.
9.
go back to reference Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18PubMedPubMedCentral Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18PubMedPubMedCentral
10.
go back to reference Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119:47–56.PubMed Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119:47–56.PubMed
11.
go back to reference Tsokos M, Reichelt U, Nierhaus A, Püschel K (2001) Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis. Int J Legal Med 114:237–243.PubMed Tsokos M, Reichelt U, Nierhaus A, Püschel K (2001) Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis. Int J Legal Med 114:237–243.PubMed
12.
go back to reference Soar J, Nolan JP, Böttiger BW, Perkins GD, Loot C, Carli P, Pellis T, Sandroni C, Skrifvars MB, Smith GB, Sunde K, Deakin CD et al (2015) European resuscitation council guidelines for resuscitation 2015. Section 3. Adult advanced life support. Resuscitation 95:100–147PubMed Soar J, Nolan JP, Böttiger BW, Perkins GD, Loot C, Carli P, Pellis T, Sandroni C, Skrifvars MB, Smith GB, Sunde K, Deakin CD et al (2015) European resuscitation council guidelines for resuscitation 2015. Section 3. Adult advanced life support. Resuscitation 95:100–147PubMed
13.
go back to reference Hess C, Krueger L, Unger M, Madea B (2017) Freeze- and -thaw stability and long-term-stability of 84 synthetic cannabinoids in serum. Drug Test Anal 9:1506–1511PubMed Hess C, Krueger L, Unger M, Madea B (2017) Freeze- and -thaw stability and long-term-stability of 84 synthetic cannabinoids in serum. Drug Test Anal 9:1506–1511PubMed
14.
go back to reference German Medical Assocation (2015) Revision of the “Guideline of the German Medical Association on quality assurance in medical laboratory examinations - Rili-BAEK”. J Lab Med 39:26–69 German Medical Assocation (2015) Revision of the “Guideline of the German Medical Association on quality assurance in medical laboratory examinations - Rili-BAEK”. J Lab Med 39:26–69
15.
go back to reference Ishikawa T, Hamel M, Zhu B-L, Li D-R, Zhao D, Michiue T, Maeda H (2008) Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int 179:135–143PubMed Ishikawa T, Hamel M, Zhu B-L, Li D-R, Zhao D, Michiue T, Maeda H (2008) Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int 179:135–143PubMed
16.
go back to reference Palmiere C, Bardy D, Mangin P, Augsburger M (2013) Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis. J Inf Secur 67:545–555 Palmiere C, Bardy D, Mangin P, Augsburger M (2013) Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis. J Inf Secur 67:545–555
17.
go back to reference Bode-Jänisch S, Schütz S, Schmidt A, Tschernig T, Debertin AS, Fieguth A, Hagemeier L, Teske J, Suerbaum S, Klintschar M, Bange FC (2013) Serum procalcitonin levels in the postmortem diagnosis of sepsis. Forensic Sci Int 226:266–272PubMed Bode-Jänisch S, Schütz S, Schmidt A, Tschernig T, Debertin AS, Fieguth A, Hagemeier L, Teske J, Suerbaum S, Klintschar M, Bange FC (2013) Serum procalcitonin levels in the postmortem diagnosis of sepsis. Forensic Sci Int 226:266–272PubMed
18.
go back to reference Majdan M, Plancikova D, Brazinova A, Rusnak M, Nieboer D, Feigin V, Maas A (2016) Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis. Lancet Public Health 1:e76–e83PubMed Majdan M, Plancikova D, Brazinova A, Rusnak M, Nieboer D, Feigin V, Maas A (2016) Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis. Lancet Public Health 1:e76–e83PubMed
19.
go back to reference Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H (2016) Traumatic brain injuries. Nat Rev Dis Primers 2:16084PubMed Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H (2016) Traumatic brain injuries. Nat Rev Dis Primers 2:16084PubMed
20.
go back to reference Chirica VI (2017) Useful markers to assess traumatic and hypoxic brain injury. Rom J Legal Med 25:146–151 Chirica VI (2017) Useful markers to assess traumatic and hypoxic brain injury. Rom J Legal Med 25:146–151
21.
go back to reference Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT (2018) An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 18:165–180PubMedPubMedCentral Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT (2018) An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn 18:165–180PubMedPubMedCentral
22.
go back to reference Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006a) Postmortem serum protein S100B levels with regard to the cause of death involving brain damage in medicolegal autopsy cases. Legal Med 8:71–77PubMed Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006a) Postmortem serum protein S100B levels with regard to the cause of death involving brain damage in medicolegal autopsy cases. Legal Med 8:71–77PubMed
23.
go back to reference Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006b) Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy. Legal Med 8:78–85PubMed Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006b) Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy. Legal Med 8:78–85PubMed
24.
go back to reference Goede A, Dreßler J, Sommer G, Schober K, Franke H, Ondruschka B (2015) Wundalterdiagnostik nach letalem Schädel-Hirn-Trauma. Rechtsmedizin 25:261–267 Goede A, Dreßler J, Sommer G, Schober K, Franke H, Ondruschka B (2015) Wundalterdiagnostik nach letalem Schädel-Hirn-Trauma. Rechtsmedizin 25:261–267
25.
go back to reference Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dreßler J (2013) S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases. J Neurotrauma 30:1862–1871 Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dreßler J (2013) S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases. J Neurotrauma 30:1862–1871
26.
go back to reference Osuna E, Perez-Carceles MD, Luna A, Pounder DJ (1992) Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult. Forensic Sci Int 52:193–198PubMed Osuna E, Perez-Carceles MD, Luna A, Pounder DJ (1992) Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult. Forensic Sci Int 52:193–198PubMed
27.
go back to reference Raabe A, Kopetsch O, Groß U, Zimmermann M, Gebhart P (2003) Measurements of serum S-100B protein: effects of storage time and temperature on pre-analytical stability. Clin Chem Lab Med 41:700–703PubMed Raabe A, Kopetsch O, Groß U, Zimmermann M, Gebhart P (2003) Measurements of serum S-100B protein: effects of storage time and temperature on pre-analytical stability. Clin Chem Lab Med 41:700–703PubMed
28.
go back to reference Beaudeux JL, Léger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ (2000) Influence of hemolysis on the measurement of S-100 protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 46:989–990PubMed Beaudeux JL, Léger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ (2000) Influence of hemolysis on the measurement of S-100 protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 46:989–990PubMed
29.
go back to reference Missler U, Wiesmann M, Wittmann G (1999) Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 45:138–141PubMed Missler U, Wiesmann M, Wittmann G (1999) Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 45:138–141PubMed
30.
go back to reference Ramont L, Thoannes H, Volondat, Chastang F, Millet MC, Maquart FX (2005) Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 43:1215–1217PubMed Ramont L, Thoannes H, Volondat, Chastang F, Millet MC, Maquart FX (2005) Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 43:1215–1217PubMed
31.
go back to reference Verfaillie CJ, Delanghe JR (2010) Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med 48:891–892PubMed Verfaillie CJ, Delanghe JR (2010) Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med 48:891–892PubMed
32.
go back to reference Korley FK, Diaz-Arrastia R, Wu AH, Yue JK, Manley GT, Sair HI, Van Eyk J, Everett AD et al (2016) Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma 33:215–225PubMedPubMedCentral Korley FK, Diaz-Arrastia R, Wu AH, Yue JK, Manley GT, Sair HI, Van Eyk J, Everett AD et al (2016) Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma 33:215–225PubMedPubMedCentral
33.
go back to reference Failla MD, Conley YP, Wagner AK (2016) Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles. Neurorehabil Neural Repair 30:83–93PubMed Failla MD, Conley YP, Wagner AK (2016) Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles. Neurorehabil Neural Repair 30:83–93PubMed
34.
go back to reference Tsokos M (2007) Postmortem diagnosis of sepsis. Forensic Sci Int 165:155–164PubMed Tsokos M (2007) Postmortem diagnosis of sepsis. Forensic Sci Int 165:155–164PubMed
35.
go back to reference Mimasaka S, Funayama M, Hashiyada M, Nata M, Tsunenari S (2007) Significance of levels of IL-6 and IL-8 after trauma. A study of 11 cytokines post-mortem using multiplex immunoassay. Injury 38:1047–1051PubMed Mimasaka S, Funayama M, Hashiyada M, Nata M, Tsunenari S (2007) Significance of levels of IL-6 and IL-8 after trauma. A study of 11 cytokines post-mortem using multiplex immunoassay. Injury 38:1047–1051PubMed
36.
go back to reference Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2012) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med 126:505–512PubMed Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2012) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med 126:505–512PubMed
37.
go back to reference Fujita MQ, Zhu B-L, Ishida K, Quan L, Oritani S, Maeda H (2002) Serum C-reactive protein levels in postmortem blood—an analysis with special reference to the cause of death and survival time. Forensic Sci Int 130:160–166PubMed Fujita MQ, Zhu B-L, Ishida K, Quan L, Oritani S, Maeda H (2002) Serum C-reactive protein levels in postmortem blood—an analysis with special reference to the cause of death and survival time. Forensic Sci Int 130:160–166PubMed
38.
go back to reference Astrup BS, Thomsen JL (2007) The routine use of C-reactive protein in forensic investigations. Forensic Sci Int 172:49–55PubMed Astrup BS, Thomsen JL (2007) The routine use of C-reactive protein in forensic investigations. Forensic Sci Int 172:49–55PubMed
39.
go back to reference Maeda H, Zhu B-L, Bessho Y, Ishikawa T, Quan L, Michiue T, Zhao D, Li D-R, Komatsu A (2008) Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia. Forensic Sci Med Pathol 4:175–180PubMed Maeda H, Zhu B-L, Bessho Y, Ishikawa T, Quan L, Michiue T, Zhao D, Li D-R, Komatsu A (2008) Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia. Forensic Sci Med Pathol 4:175–180PubMed
40.
go back to reference Uhlin-Hansen L (2001) C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels. Forensic Sci Int 124:32–35PubMed Uhlin-Hansen L (2001) C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels. Forensic Sci Int 124:32–35PubMed
41.
go back to reference Palmiere C, Augsburger M (2014) Markers for sepsis diagnosis in the forensic setting. State of the art. Croat Med J 55:103–114PubMed Palmiere C, Augsburger M (2014) Markers for sepsis diagnosis in the forensic setting. State of the art. Croat Med J 55:103–114PubMed
42.
go back to reference Schmidt S, Windgassen M, Nofer J-R, Pfeiffer H, Ribbecke S, Schmeling A (2015) Procalcitonin as a postmortem sepsis marker. A comparison of the validity of results obtained from blood serum, aqueous humour and cerebrospinal fluid. Int J Legal Med 129:117–123PubMed Schmidt S, Windgassen M, Nofer J-R, Pfeiffer H, Ribbecke S, Schmeling A (2015) Procalcitonin as a postmortem sepsis marker. A comparison of the validity of results obtained from blood serum, aqueous humour and cerebrospinal fluid. Int J Legal Med 129:117–123PubMed
43.
go back to reference Ramsthaler F, Kettner M, Mall G, Bratzke H (2008) The use of rapid diagnostic test of procalcitonin serum levels for the postmortem diagnosis of sepsis. Forensic Sci Int 178:139–145PubMed Ramsthaler F, Kettner M, Mall G, Bratzke H (2008) The use of rapid diagnostic test of procalcitonin serum levels for the postmortem diagnosis of sepsis. Forensic Sci Int 178:139–145PubMed
44.
go back to reference Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schüttler J (1997) Procalcitonin - influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Clin Chem Lab Med 35:597–602. Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic A, Schüttler J (1997) Procalcitonin - influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Clin Chem Lab Med 35:597–602.
45.
go back to reference Madea B, Musshoff F (2007) Post-mortem biochemistry. Forensic Sci Int 165:165–171PubMed Madea B, Musshoff F (2007) Post-mortem biochemistry. Forensic Sci Int 165:165–171PubMed
46.
go back to reference Flanagan RJ (2017) Post-mortem biochemistry and toxicology. Arab J For Sci For Med 1:540–552 Flanagan RJ (2017) Post-mortem biochemistry and toxicology. Arab J For Sci For Med 1:540–552
47.
go back to reference Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J (2009) Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods 177:469–478PubMed Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J (2009) Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods 177:469–478PubMed
Metadata
Title
Post-mortem in situ stability of serum markers of cerebral damage and acute phase response
Authors
Benjamin Ondruschka
Lina Woydt
Michael Bernhard
Heike Franke
Holger Kirsten
Sabine Löffler
Dirk Pohlers
Niels Hammer
Jan Dreßler
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 3/2019
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-018-1925-2

Other articles of this Issue 3/2019

International Journal of Legal Medicine 3/2019 Go to the issue